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Abstract 
Background: Post-traumatic stress disorder (PTSD) is a potentially chronic and disabling 
disorder that affects a significant minority of youth exposed to trauma. Previous studies have 
concluded that trauma-focused cognitive behavioural therapy (TF-CBT) is an effective 
treatment for PTSD in youth, but the relative strengths of different psychological therapies 
are poorly understood. 
Methods: We undertook a systematic review and network meta-analyses of psychological 
and psychosocial interventions for children and young people with PTSD. Outcomes 
included PTSD symptom change scores post-treatment and at 1-4-month follow-up, and 
remission post-treatment. 
Results: We included 32 trials of 17 interventions and 2,260 participants. Overall, the 
evidence was of moderate-to-low quality. No inconsistency was detected between direct and 
indirect evidence. Individual forms of TF-CBT showed consistently large effects in reducing 
PTSD symptoms post-treatment compared with waitlist. The order of interventions by 
descending magnitude of effect versus waitlist was: cognitive therapy for PTSD (SMD -2.94, 
95%CrI -3.94 to -1.95), combined somatic/cognitive therapies, child-parent psychotherapy, 
combined TF-CBT/parent training, meditation, narrative exposure, exposure/prolonged 
exposure, play therapy, Cohen TF-CBT/cognitive processing therapy (CPT), eye movement 
desensitisation and reprocessing (EMDR), parent training, group TF-CBT, supportive 
counselling, and family therapy (SMD -0.37, 95%CrI -1.60 to 0.84). Results for parent 
training, supportive counselling and family therapy were inconclusive. Cohen TF-CBT/CPT, 
group TF-CBT and supportive counselling had the largest evidence base. Results regarding 
changes in PTSD symptoms at follow-up and remission post-treatment were uncertain due 
to limited evidence.  
Conclusions: TF-CBT, in particular individual forms, appears to be most effective in the 
management of PTSD in youth. EMDR is effective but to a lesser extent. Supportive 
counselling does not appear to be effective. Results suggest a large positive effect for 
emotional freedom technique, child-parent psychotherapy, combined TF-CBT/parent 
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training, and meditation, but further research is needed to confirm these findings as they 
were based on very limited evidence. 
Keywords: post-traumatic stress disorder; network meta-analysis; intervention 
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INTRODUCTION 
More than half of children and young people are exposed to potentially traumatic events 
(Landolt, Schnyder, Maier, Schoenbucher, & Mohler-Kuo, 2013; McLaughlin et al., 2013) 
with a significant minority of exposed youth going on to develop post-traumatic stress 
disorder (PTSD) (Alisic et al., 2014). One twin study of UK youth suggested a population 
prevalence of 3% (Fisher et al., 2015). PTSD may be chronic (Morgan, Scourfield, Williams, 
Jasper, & Lewis, 2003; Yule et al., 2000) and have a significant impact on broader 
development, impairing social, academic and occupational functioning (Bolton, O'Ryan, 
Udwin, Boyle, & Yule, 2000). Given its chronicity and impact, it is not surprising that a variety 
of treatments have been proposed for this condition in youth, including different forms of 
trauma-focused cognitive behaviour therapy (TF-CBT), eye movement desensitisation and 
reprocessing (EMDR), child-parent psychotherapy, and parent training. A number of 
systematic reviews and meta-analyses have evaluated the effectiveness of psychological 
and psychosocial treatments for PTSD in children and young people (Cary & McMillen, 
2012; Gutermann et al., 2016; Harvey & Taylor, 2010; Kowalik, Weller, Venter, & Drachman, 
2011; Morina, Koerssen, & Pollet, 2016; Silverman et al., 2008). The consensus to date is 
that TF-CBT is an effective treatment for PTSD in children and young people, with some also 
concluding that EMDR is effective but to a lesser extent. These studies have made limited 
comparisons of a narrow range of treatments and used standard meta-analytic techniques to 
synthesise direct evidence from randomised controlled trials (RCTs). This approach does not 
allow the relative effectiveness between treatments to be assessed, unless these have been 
compared in a head-to-head trial. 
 
Network meta-analysis (NMA) is a generalisation of standard pairwise meta-analysis to data 
structures that include, for example, A versus B, B versus C, and A versus C trials (Lu & 
Ades, 2004). NMA strengthens inference concerning the relative effect of two treatments by 
including both direct and indirect treatment comparisons. This means that NMA allows 
estimation of the relative effects of treatments that may not have been directly compared in 
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RCTs. Simultaneous estimation of all relative effects for any number of treatments is 
possible, provided that treatments are connected LQDVLQJOHµQHWZRUNRIHYLGHQFH¶WKDWLV
every treatment is linked to at least one of the other treatments under assessment, through 
direct comparisons (Caldwell, Ades, & Higgins, 2005; Dias, Sutton, Ades, & Welton, 2013a; 
Mavridis, Giannatsi, Cipriani, & Salanti, 2015). 
 
The objective of this study was to examine the relative effectiveness of psychological, 
psychosocial and other non-pharmacological treatments of PTSD in children and young 
people using NMA.  
 
METHODS 
The analyses presented here supported the updating of national guidance for the 
management of PTSD in England, published by the National Institute for Health and Care 
Excellence (NICE) (National Institute for Health and Care Excellence, 2018). The guideline 
was developed by a guideline committee, an independent multi-disciplinary group of clinical 
academics, health professionals and service user and carer representatives with expertise 
and experience in the field of PTSD. 
 
Search strategy 
A search for RCTs of treatments for people with clinically important post-traumatic stress 
symptoms was conducted in the databases MEDLINE, Embase, PsycINFO, CINAHL and 
The Cochrane Library. Databases were searched using relevant medical subject headings, 
free-text terms and study type filters where appropriate. Studies published in languages 
other than English were excluded following NICE guidance (National Institute for Health and 
Care Excellence 2014); evidence suggests that use of language restrictions in systematic 
review-based meta-analyses in conventional medicine does not introduce systematic bias 
(Morrison et al., 2012). The aim of the search was to update the evidence included in the 
previous NICE PTSD guideline, published in 2005. The search was undertaken in 
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January/February 2017 with re-runs being performed in January 2018. Online Appendix 1 
provides full details of the databases and the search terms used. 
 
Selection criteria for the systematic review and the network meta-analysis 
A systematic review of psychological, psychosocial and other non-pharmacological 
interventions targeted at clinically important post-traumatic stress symptoms in children and 
young people (aged under 18 years) more than one month after a traumatic event was 
carried out according to Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009). Clinically 
important post-traumatic stress symptoms were defined by either a diagnosis of PTSD 
according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), the World 
Health Organization (WHO) International Classification of Diseases (ICD) or similar criteria, 
or clinically significant PTSD symptoms, indicated by baseline PTSD symptom scores above 
threshold on a validated scale. Critical outcomes included PTSD symptom endpoint or 
change scores on a validated PTSD scale; response; and recovery or remission defined 
either as number of the people no longer meeting DSM, ICD or similar diagnostic criteria for 
PTSD, or with PTSD symptom scores below threshold on a validated scale. 
 
For quality assurance of study identification, the titles and abstracts of identified studies were 
screened by two reviewers for inclusion against criteria specified in the guideline review 
protocols, until a good inter-rater reliability was observed (percentage agreement စ 90% or 
Kappa statistic K>0.60). Initially 10% of references were double-screened; as inter-rater 
agreement was good for this initial 10%, the remaining references were screened by one 
reviewer. All primary-level studies included after the first scan of citations were acquired in 
full and re-evaluated for eligibility at the time of being entered into a study database 
(standardised template created in Microsoft Excel). At least 10% of data extraction was 
double-coded. Discrepancies or difficulties with coding were resolved through discussion 
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between reviewers or the opinion of a third reviewer was sought. Data were extracted on 
study characteristics, intervention details, outcome data, and risk of bias. 
 
For the NMA, we considered only treatments tested on children and young people with 
clinically important post-traumatic stress symptoms more than three months after a traumatic 
event. Treatments that were not connected to the treatment network were excluded from the 
NMAs.  
 
The NMA assessed different interventions within the TF-CBT class. TF-CBT is a broad class 
of psychological interventions that predominantly use trauma-focused cognitive, behavioural 
or cognitive-behavioural techniques and exposure approaches to treatment. Although some 
interventions place their main emphasis on exposure (e.g. imaginal reliving, producing a 
written narrative or in vivo exposure) and others on cognitive techniques (e.g. restructuring 
of trauma-related appraisals), most use a combination. Interventions included in the TF-CBT 
class, such as cognitive therapy for PTSD, TF-CBT largely based on the Cohen manual 
(Cohen, Mannarino, & Deblinger, 2006) and cognitive processing therapy, narrative 
exposure, exposure/prolonged exposure, and group TF-CBT, were analysed as separate 
treatments in the network, in order to explore any differences in effectiveness among them. 
The sole study of cognitive processing therapy was collapsed into a group with TF-CBT 
largely based on the Cohen manual, given the degree of overlap between these therapies 
(e.g. structured format, psychoeducation, production of a trauma narrative, cognitive 
restructuring). Combined somatic/cognitive therapies only included emotional freedom 
technique, as evidence was only available for this treatment. Treatment as usual (TAU), 
according to study descriptions, ranged from providing information on post-traumatic 
symptom patterns and encouragement to access therapy, to any care required, including 
psychotherapy, medication or psychoeducational family counselling, as judged by the 
clinician. Waitlist and no treatment arms were included in the same node and analysed 
together, as there were very few no treatment arms (2) compared with waitlist (14) and 
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keeping them separate was considered to add no value in the analyses. Nevertheless, we 
undertook a sensitivity analysis in which we kept waitlist and no treatment in separate nodes, 
to explore the impact of our decision to merge and analyse these two controls together on 
the results.   
 
The NMA considered two outcomes: PTSD symptom change scores and remission. Data on 
these outcomes were mostly reported at treatment endpoint. Moreover, a number of studies 
reported data on PTSD symptom change scores at 1-4-month follow-up; in contrast, 
remission data at 1-4-month follow-up were only available for the comparison of group TF-
CBT versus waitlist. Beyond 1-4 months of follow-up, available data were very sparse for 
both outcomes. Based on the availability of data on the two outcomes of interest, three 
separate NMAs were conducted using data for 3 outcomes, respectively:  
x PTSD symptom change scores between baseline and treatment endpoint 
x PTSD symptom change scores between baseline and 1-4-month follow-up 
x Remission at treatment endpoint 
 
PTSD symptom change scores derived from self-rated symptom scales were prioritised over 
those derived from clinician-rated symptom scales if both were available in the same study, 
as they were deemed to better capture symptoms experienced by children and young people 
with PTSD. Intention-to-treat (ITT) data, obtained after imputation of missing data, were 
SULRULWLVHGRYHUFRPSOHWHUV¶GDWDLIERWKZHUHDYDLODEOHLQWKHVDPHVWXG\ 
 
The study protocol was published on the NICE website during consultation of the draft 
guidance with registered stakeholders (https://www.nice.org.uk/guidance/ng116/history). The 
guideline systematic review protocol and the additional inclusion criteria applied for the NMA 
are provided in online Appendix 2.  
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Statistical analysis 
NMAs were conducted within a Bayesian framework using Markov Chain Monte Carlo 
simulation techniques implemented in WinBUGS 1.4.3 (Lunn, Thomas, Best, & 
Spiegelhalter, 2000; Spiegelhalter, Thomas, Best, & Lunn, 2003). An overview of the 
approach and methods adopted is provided below. Full details of the statistical analysis and 
the WinBUGS codes used to synthesise changes in PTSD symptom scores and 
dichotomous remission data are reported in online Appendix 3. 
 
For the synthesis of continuous data (changes in PTSD symptom scores), a linear model 
with a normal likelihood and identity link was used (Dias, Sutton, Ades, & Welton, 2013a; 
Dias, Ades, Welton, Jansen, & Sutton, 2018). Because the RCTs included in the NMAs used 
different continuous scales to report change in PTSD symptoms, results were expressed in 
the form of the Standardised Mean Difference (SMD) between pairs of interventions. For the 
synthesis of dichotomous data (remission), a generalised linear model with binomial 
likelihood and logit link was used (Dias et al., 2013a, 2018). The output of this analysis was 
the log-odds ratios (LORs) between pairs of interventions. The suitability of fixed and 
random effects models (model fit) was assessed and compared and the most suitable model 
(fixed or random effects) was selected for the analysis of each of the three outcomes. 
 
For each analysis we report mean relative effects (either SMD or LOR) with 95% credible 
intervals (CrI). We also report mean ranks with 95% CrI for every treatment in each analysis, 
where a rank of 1 indicates highest effectiveness. Results were interpreted in terms of 
µHYLGHQFHRIHIIHFW¶UDWKHUWKDQµVWDWLVWLFDOVLJQLILFDQFH¶ (Pike, 2019), and this was 
determined based on whether the 95% CrI crossed the line of no effect. Although no cut-off 
points were used in order to judge the magnitude of effect, in general a SMD value of 0.2 to 
0.3 was deemed to indicate a small effect, a value around 0.5 a medium effect, and a value 
of 0.8 and above a large effect (Cohen, 1969). 
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Inconsistency checks 
A basic assumption of NMA methods is that direct and indirect evidence estimate the same 
parameter, that is, the relative effect between A and B measured directly from an A versus B 
trial is the same as the relative effect between A and B estimated indirectly from A versus C 
and B versus C trials, i.e. the evidence is consistent (this has also been termed the similarity 
or transitivity assumption (Mavridis et al., 2015)). Inconsistency arises when there is a 
conflict between direct evidence (from an A versus B trial) and indirect evidence (gained 
from A versus C and B versus C trials) and can only be assessed when there are closed 
loops of evidence on 3 treatments that are informed by at least 3 distinct trials (van 
Valkenhoef, Dias, Ades, & Welton, 2016). The assumption of consistency between indirect 
and direct evidence was explored by undertaking global inconsistency tests (Dias et al., 
2013b) and node-split testing (Dias et al., 2013b; van Valkenhoef & Kuiper, 2016). When 
evidence of inconsistency was found, studies contributing to loops of evidence where there 
might be inconsistency were checked for data accuracy and analyses were repeated if 
corrections in the data extraction were made. However, if evidence of inconsistency was still 
present following data corrections, no studies were excluded from the analysis, as their 
results could not be considered as less valid than those of other studies solely because of 
the inconsistency findings. Nevertheless, the presence of inconsistency in the NMA was 
highlighted and results were interpreted accordingly. 
 
Details of the methods used to test inconsistency and the WinBUGS code for the 
inconsistency model are provided in online Appendix 4.  
 
Threshold analysis 
Threshold analysis was undertaken to test the robustness of treatment recommendations 
based on the NMA to potential biases or sampling variation in the included evidence 
(Phillippo et al., 2019). The results of threshold analysis describe how much each data point 
could change (for example if adjusted for bias) before the conclusion changes and what the 
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revised conclusion would be. Threshold analyses were carried out at two levels: (i) at a study 
level, assessing the influence of individual study estimates on the conclusion of the analysis 
and (ii) at a contrast level, where the influence of the combined evidence on each treatment 
contrast was considered (Caldwell et al., 2016; Phillippo, Dias, Ades, Didelez & Welton, 
2018; Phillippo et al., 2019). Full methods used for threshold analysis are provided in online 
Appendix 5. 
 
RESULTS 
Studies and treatments 
The systematic literature search identified 141 studies potentially eligible for the systematic 
review, 104 of which were excluded. Five more studies were excluded as they did not meet 
criteria for the NMA, leaving 32 eligible studies that reported one or more outcomes of 
interest (Figure 1). The characteristics of included studies are reported in online Appendix 6, 
while a list of excluded studies, with reasons for exclusion, is provided in online Appendix 7. 
 
The NMA of changes in PTSD symptom scores between baseline and treatment endpoint 
was informed by 29 RCTs that assessed 17 interventions tested on 1960 participants. The 
NMA of changes in PTSD symptom scores between baseline and 1-4-month follow-up 
included 10 RCTs, 608 participants and 12 interventions. The NMA of remission at treatment 
endpoint considered 9 studies, 485 participants and 7 interventions. 
 
The three respective networks are shown in Figure 2. Full data utilised in each NMA are 
shown in online Appendix 8. 
 
Risk of bias assessment 
All 32 included trials were assessed for risk of bias using the Cochrane risk of bias tool 
(Higgins & Green, 2011). Sequence generation and allocation concealment were adequately 
described in eleven and seven trials, respectively. Trials were regarded at high risk of bias 
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for lack of participant and provider masking. In four studies, a clinician-rated scale was used 
and assessors were unaware of treatment assignment, in three trials it was unclear if the 
assessors were blinded, in two studies a non-blind clinician-rated scale was used, and in 23 
studies a self-rated scale was used meaning that raters were non-blind but were less likely 
to have a conflict of interest in terms of detection bias. Attrition was high in two trials and 
unclear in eleven studies. However, we favoured ITT analysis and, for the remission 
outcome, we conservatively treated drop outs as failing to remit (rather than as remitters). 
Included trials reported a variety of outcomes. Only four trials were registered on a trials 
database and reported all listed outcomes. Consequently, most studies were judged as 
being at unclear risk of reporting bias. Other potential biases were only identified in one 
study which was rated as high risk due to a potential conflict of interest. An overview of the 
WULDOV¶ULVNRIELDVDVVHVVPHQWLVSURYLGHGLQRQOLQHAppendix 9. 
 
NMA model fit statistics 
In the NMA of changes in PTSD symptom scores between baseline and treatment endpoint, 
the random effects model provided a better fit over the fixed effect model; however, the 
between-trial standard deviation (sd), which measures the heterogeneity of treatment effects 
estimated by trials within contrasts, was moderate-to-high when compared with the size of 
the intervention effect estimates (posterior median sd 0.56, 95% CrI 0.37 to 0.89). 
 
In the NMA of changes in PTSD symptom scores between baseline and 1-4-month follow-
up, the random effects model provided a better fit over the fixed effect model; however, due 
to limited evidence, the posterior distribution for the between-trial heterogeneity was 
implausibly wide. Therefore, an informative prior distribution on the logged between-study 
variance was used (Rhodes, Turner, & Higgins, 2015) (see online Appendix 3), which 
resulted in a moderate-to-high between-study heterogeneity compared with the size of 
treatment effects (posterior median sd 0.46, 95% CrI 0.10 to 1.20).  
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In the NMA of remission at treatment endpoint, both fixed and random effects models 
provided good fit; therefore, the simpler, fixed effect model was chosen.  
 
Full details of model fit statistics are provided in online Appendix 10. 
 
Treatment outcomes 
Results of each analysis are presented in Table 1, as mean effects with 95% CrI of each 
intervention versus waitlist, which served as the reference. In each analysis, interventions 
have been ordered from the most to the least effective, according to their mean ranking. The 
table also shows the number of participants randomised to each intervention across RCTs 
included in each analysis, and the number of RCTs that assessed each intervention in each 
of the 3 NMAs. 
 
Changes in PTSD symptom scores between baseline and treatment endpoint 
All individual forms of TF-CBT (cognitive therapy, narrative exposure therapy, 
exposure/prolonged exposure therapy, Cohen TF-CBT/CPT) showed large effects compared 
with waitlist, with the mean SMD ranging from -2.94 [95% CrI -3.94 to -1.95] for cognitive 
therapy to -1.17 [95% CrI -1.78 to -0.54] for Cohen TF-CBT/CPT, although for a number of 
interventions effects were characterised by considerable uncertainty, as indicated by wide 
95% CrI; nevertheless, 95% CrI did not cross the line of no effect for any of the individual 
forms of TF-CBT, suggesting evidence of effect. Cognitive therapy for PTSD appeared to be 
the most effective intervention; however, this finding was based on a very narrow evidence 
base (N=25), focused on single-trauma PTSD. Cohen TF-CBT/CPT showed the smallest 
positive effect amongst individual forms of TF-CBT but had the largest evidence base 
(N=349) and its effect was characterised by relatively narrow CrI. Group TF-CBT showed 
evidence of a positive effect, albeit lower than that of individual forms of TF-CBT (mean SMD 
-0.91, 95% CrI -1.48 to -0.34). 
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Other interventions with large effects versus waitlist and 95% CrI that did not cross the line 
of no effect were, by order of mean ranking, combined somatic/cognitive therapies (mean 
SMD -2.14, 95% CrI -3.34 to -0.92, ranked second best intervention), child-parent 
psychotherapy, combined TF-CBT/parent training, meditation, play therapy and EMDR 
(mean SMD -0.99, 95% CrI -1.76 to -0.23). However, these interventions were tested on a 
small number of individuals (N<100 for each intervention), which may explain the wide 95% 
CrI characterising their effects and rankings. Parent training, supportive counselling and 
family therapy showed smaller and inconclusive effects, as 95% CrI crossed the line of no 
effect in comparisons with waitlist; with the exception of supportive counselling (N=180) 
these findings were based on limited evidence (N<100 for each of the other two 
interventions). 
 
The large uncertainty in the results for most interventions is also indicated by the wide 95% 
CrI around mean rankings, for example, combined somatic/cognitive therapies could 
plausibly be ranked between the 1st and 11th place according to the NMA model. 
 
Changes in PTSD symptom scores between baseline and 1-4-month follow-up 
Combined somatic/cognitive therapies showed the largest effect versus waitlist (mean SMD -
1.80, 95% CrI -3.01 to -0.58), followed by Cohen TF-CBT/CPT, group TF-CBT, and 
combined TF-CBT/parent training (mean SMD -1.49, 95% CrI -2.90 to -0.07). Of the 
remaining interventions, narrative exposure was the only one for which there was evidence 
of effect compared with waitlist, as suggested by 95% CrI that did not cross the line of no 
effect (mean SMD -0.94, 95% CrI -1.84 to -0.04). With the exception of group TF-CBT 
(N=112), all other interventions were tested on small numbers of participants, and this is 
reflected in the wide 95% CrI around effects and rankings (Table 1). 
 
Remission at treatment endpoint 
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All individual forms of TF-CBT showed better effects than waitlist and 95% CrI that did not 
cross the line of no effect. Narrative exposure showed the highest mean effect (mean LOR 
2.81, 95% CrI 0.87 to 5.13), followed by cognitive therapy for PTSD, exposure/prolonged 
exposure therapy, and Cohen TF-CBT/CPT (mean LOR 0.89, 95% CrI 0.15 to 1.64). 
Supportive counselling showed a small and inconclusive effect versus waitlist (mean LOR 
0.15, 95% CrI -0.98 to 1.28). With the exception of Cohen TF-CBT/CPT (N=158), all other 
interventions were tested on a small number of trial participants (N<100), and this is 
reflected in the uncertainty of the results as indicated by wide 95% CrI around effects and 
rankings. 
 
Detailed results between all pairs of treatments examined in the NMAs as well as results 
from available direct (head-to-head) comparisons are reported in online Appendix 11. It can 
be seen that the NMA and pairwise results were in agreement in all cases, as indicated by 
the overlapping of credible/confidence intervals. 
 
Inconsistency checks 
No evidence of inconsistency between direct and indirect evidence was found in either NMA 
of changes in PTSD symptom scores. The network of remission at treatment endpoint had 
no closed loops of evidence, therefore inconsistency checks were not applicable. Results of 
inconsistency checks are provided in online Appendix 12. 
 
Results of threshold analysis 
TF-CBT treatments in individual form tended to be the first recommended treatment based 
on a decision rule of recommending the most efficacious treatments that have been studied 
on at least 50 trial participants (as this was considered the minimum adequate evidence that 
could support a treatment recommendation). For PTSD symptom change scores between 
baseline and treatment endpoint, the treatment recommendation of narrative exposure was 
sensitive to imprecision; this means that changes in the point estimate within its 95% CrI 
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would result in play therapy or exposure/prolonged exposure being recommended. For 
PTSD symptom change scores between baseline and 1-4 months follow-up, the 
recommendation of group CBT was also sensitive to imprecision, and narrative exposure 
would be recommended instead. Finally, in terms of remission, the recommendation of 
exposure/prolonged exposure was sensitive to imprecision, and Cohen TF-CBT/CPT would 
be recommended instead. Results of the threshold analysis are provided in online Appendix 
13. 
 
Sensitivity analysis: waitlist and no treatment analysed in separate nodes  
This analysis was only relevant for two outcomes: changes in PTSD symptom scores 
between baseline and treatment endpoint; and changes in PTSD symptom scores between 
baseline and 1-4-month follow-up. No studies included in the NMA of remission had a µno 
treatment¶ control. The NMA modes used were the same as for the base-case analyses. 
Networks, datasets and results of these sensitivity analyses are provided in online Appendix 
14. 
 
In the sensitivity analysis of changes in PTSD symptom scores between baseline and 
treatment endpoint, no treatment showed a small and uncertain positive effect compared 
with waitlist. Relative effects of all treatments versus waitlist were similar to those obtained 
from the base-case analysis and ranking was identical. Relative effects versus no treatment 
were characterised by wide 95% CrI which, for most interventions, crossed the line of no 
effect. The only interventions with evidence of effect versus no treatment were cognitive 
therapy for PTSD, combined somatic/cognitive therapies, and narrative exposure. These 
findings suggest that the base-case analysis may have overestimated the effects of active 
interventions at treatment endpoint. 
 
In the sensitivity analysis of changes in PTSD symptom scores between baseline and 1-4-
month follow-up, no treatment showed a moderate and uncertain negative effect compared 
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with waitlist. Relative effects versus waitlist were sensitive for some interventions, which 
resulted in changes in ranking compared with the base-case analysis; notably, Cohen TF-
CBT/CPT ranked in the first place, followed by combined TF-CBT/parent training, whereas 
combined somatic/cognitive therapies fell at the 3rd place in mean ranking. All interventions 
showed very large effects versus no treatment, with wide 95% CrI that did not cross the line 
of no effect with the exception of EMDR and TAU. These results suggest that the base-case 
estimates of the effects of active interventions at 1-4-month follow-up may have been 
conservative. 
 
DISCUSSION 
TF-CBT, in particular individually delivered forms such as cognitive therapy, narrative 
exposure, exposure/prolonged exposure, and Cohen TF-CBT/CPT, appear to be most 
effective in reducing PTSD symptoms and achieving remission in children and young people 
with PTSD at end of treatment. Cognitive therapy for PTSD was shown to be the most 
effective intervention in reducing PTSD symptoms at treatment endpoint (albeit based on 
small samples and only single-event trauma), followed by combined somatic/cognitive 
therapies, child-parent psychotherapy, combined TF-CBT/parent training, and meditation; 
however, results for these interventions were also based on a very limited evidence base 
(each tested on N<50 across trials). Play therapy showed similar effects to 
exposure/prolonged exposure. EMDR and group TF-CBT also appeared to be effective in 
reducing PTSD symptoms in children and young people with PTSD at treatment endpoint, 
but with smaller effects compared with other interventions. Parent training alone, supportive 
counselling and family therapy showed smaller effects in reducing PTSD symptoms and 
95% CrI that crossed the line of no effect in comparisons with waitlist. Supportive counselling 
appeared to have no effect in achieving remission compared with waitlist. Cohen TF-
CBT/CPT had the largest evidence base, followed by supportive counselling and group TF-
CBT. All other interventions had a narrow evidence base which was reflected, in most cases, 
in the uncertainty around the results, which should therefore be treated with caution. The 
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results of the threshold analyses reflected these findings, where recommendations of TF-
CBT forms were sensitive to imprecision or uncertainty in estimates contributing to the NMA. 
 
At 1-4-month follow-up, combined somatic/cognitive therapies appeared to be the most 
effective in retaining improvement in PTSD symptoms followed by Cohen TF-CBT/CPT, 
group CBT, and combined TF-CBT/parent training. Narrative exposure also appeared to be 
effective, to a lesser degree, in retaining effects at follow-up. Results for other interventions 
were inconclusive as 95% CrI of effects crossed the line of no effect. The results of this 
analysis should be treated with caution due to the narrow evidence base. 
 
To our knowledge, this is the first known NMA of treatments for children and young people 
with PTSD that was designed to inform a clinical guideline. The NMAs that utilised PTSD 
symptom change scores further informed the guideline economic analysis, described in a 
companion paper (Mavranezouli et al., submitted). NMA techniques enabled evidence 
synthesis from both direct and indirect comparisons between interventions, and allowed 
simultaneous inference on all treatments examined in pair-wise trial comparisons while 
respecting randomisation (Caldwell et al., 2005; Lu & Ades, 2004). Inconsistency checks 
found no inconsistency between direct and indirect evidence in the two NMAs of changes in 
PTSD symptom scores. This finding provides reassurance that the included studies were 
comparable across interventions, although it is acknowledged that between-trial 
heterogeneity was moderate-to-high. Inconsistency checks were not possible for the NMA of 
remission, as there were no closed loops of evidence within the network. Threshold analyses 
found that, among treatments studied on at least 50 patients, forms of TF-CBT are 
recommended based on efficacy, yet these recommendations are sensitive to imprecision. 
The alternative recommended treatments were play therapy or other forms of TF-CBT 
treatments. 
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The studies included in the NMAs were subject to risk of bias, in particular selection and 
reporting bias. In none of the studies were participants blinded, which was unavoidable due 
to the nature of interventions, and in most cases it was unclear whether assessors were 
blinded. As described earlier, self-rated PTSD symptom scores were preferred to clinician-
rated ones if both were reported in a study, as they were deemed to better capture 
symptoms experienced by children and young people with PTSD. However, self-rated 
assessment cannot be blinded in trials of psychological and psychosocial interventions; on 
the other hand, raters were less likely to have a conflict of interest in terms of detection bias. 
The quality and limitations of RCTs included in the analyses need to be considered when 
interpreting the results. The ITT approach that we adopted for analyses meant that all 
participants were analysed in the group to which they had been randomised and that study 
non-completers were assumed to have failed to remit. This strategy provides a conservative 
estimate of treatment effects compared with completer analysis, assuming that active 
interventions have a higher risk of drop-out compared with control conditions (this higher risk 
could be attributable to side effects, unacceptability of the active intervention, or to people 
discontinuing treatment early if their symptoms improve). 
 
We evaluated outcomes at treatment endpoint and, for PTSD symptom change scores, also 
at 1-4-month follow-up. Evidence on the long-term effectiveness of treatments for PTSD in 
youth is very limited, in particular for the outcome of remission. It is important that future 
trials address this gap in evidence.  
 
The description of TAU was not always clear and its content varied across studies; the 
diversity of TAU across RCTs is likely to have contributed to the heterogeneity observed in 
the analyses. Waitlist and no treatment arms were analysed together, as there were only two 
µQRWUHDWPHQW¶DUPVDQGNHHSLQJWKHPVHSDUDWHZDVFRQVLGHUHGWRDGGQRYDOXHLQWKH
analyses. However, it is acknowledged that the baseline effect of waitlist may be lower than 
WKDWRIµQRWUHDWPHQW¶(Furukawa et al., 2014), resulting in the relative effects of active 
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interventions having been potentially exaggerated in waitlist-controlled studies compared 
with their expected HIIHFWVYHUVXVDµQRWUHDWPHQW¶control. We tested this assumption in 
sensitivity analyses that treated waitlist and no treatment as separate interventions and 
found that in the base-case analyses effects of treatments may have been overestimated at 
treatment endpoint but may have been underestimated at 1-4-month follow-up. 
Nevertheless, overall conclusions were not materially different. It is noted that no treatment 
was only tested on 32 trial participants and had limited connections into the 1-4-month 
follow-up network, therefore introducing considerable uncertainty into these sensitivity 
analyses, which need to be treated with caution. 
 
Clinical implications 
The support for TF-CBT demonstrated in these NMAs is consistent with the findings of 
earlier meta-analytic reviews. Moreover, the use of an NMA design revealed further 
noteworthy results that would not be possible to obtain with standard forms of meta-analysis. 
The lack of any significant difference between supportive counselling and waitlist shown 
here warns against the use of this interventLRQDVD³IDOO-EDFN´RSWLRQIRUH[DPSOH where a 
therapist trained in a TF-CBT approach is not available or a client has refused to engage 
with TF-CBT; these findings may also bring into question the suitability of this intervention as 
a control treatment in future trials. While the few studies to have compared TF-CBT with 
EMDR have not shown any significant differences, the overall pattern of evidence 
incorporated in these NMAs suggests that EMDR, while more effective than waitlist or no 
treatment, is likely to have a lower effect than most individual forms of TF-CBT. Results, 
therefore, support routine use of different forms of TF-CBT for children and young people 
with TF-CBT, and, potentially, EMDR as an alternative treatment option. Results show a 
positive effect for a number of other treatment approaches, such as emotional freedom 
technique, child-parent psychotherapy, combined TF-CBT/parent training, and meditation, 
but further research is needed to establish their efficacy in this population. 
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CONCLUSION 
TF-CBT, in particular individually delivered forms, appears to be most effective in the 
management of PTSD in youth. Results from the threshold analyses for the most part 
support this finding, with play therapy potentially being effective in managing PTSD 
symptoms at treatment endpoint. EMDR is effective but to a lesser extent. Supportive 
counselling does not appear to be effective in this population. Results suggest a large 
positive effect for emotional freedom technique, child-parent psychotherapy, combined TF-
CBT/parent training, and meditation, but further research is needed to confirm these findings 
as they were based on very limited evidence. There is a need for well-conducted head-to-
head RCTs that examine the relative effectiveness of interventions with promising evidence, 
including comparative assessment of their longer term effects, in order to establish their 
long-term relative clinical and cost-effectiveness. 
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Key points 
x PTSD is a potentially chronic and disabling disorder that affects a significant 
minority of youth exposed to trauma. 
x A number of psychological and psychosocial therapies are available for the 
treatment of PTSD in youth. 
x NMA techniques enable evidence synthesis from direct and indirect 
comparisons between interventions, and allow simultaneous inference on all 
treatments that form a network of evidence while respecting randomisation. 
x TF-CBT, in particular individually delivered forms, appears to be most effective 
in the management of PTSD in youth. EMDR is effective but to a lesser extent. 
Supportive counselling does not appear to be effective in this population. 
x Results support routine use of different forms of TF-CBT for youth with TF-
CBT, and, potentially, EMDR as an alternative treatment option. 
x Results suggest a large positive effect for emotional freedom technique, child-
parent psychotherapy, combined TF-CBT/parent training, and meditation, but 
further research is needed to confirm these findings as they were based on 
very limited evidence. 
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Table 1. Network meta-analyses of psychological and psychosocial treatments for PTSD in children and young people: interventions, 
magnitude of evidence base and results 
 
Changes in PTSD symptom scores between baseline and treatment endpoint 
N total = 1960; k total = 29; 63 study arms 
Intervention N k Mean SMD (95% CrI) vs waitlist Mean ranking (95% CrI) 
[TF-CBT] cognitive therapy 25 2 -2.94 (-3.94 to -1.95) 1.58 (1 to 4) 
Combined somatic/cognitive therapies 20 1 -2.14 (-3.34 to -0.92) 3.77 (1 to 11) 
Child-parent psychotherapy 36 1 -2.16 (-4.02 to -0.26) 4.13 (1 to 13) 
TF-CBT & parent training 12 1 -1.79 (-3.15 to -0.45) 5.40 (1 to 14) 
Meditation 38 1 -1.67 (-2.94 to -0.41) 5.96 (1 to 14) 
[TF-CBT] narrative exposure 73 3 -1.49 (-2.25 to -0.74) 6.57 (3 to 12) 
[TF-CBT] exposure/PE 83 4 -1.34 (-2.15 to -0.51) 7.51 (3 to 12) 
Play therapy 83 2 -1.35 (-2.48 to -0.20) 7.60 (2 to 14) 
[TF-CBT] Cohen TF-CBT/CPT 349 8 -1.17 (-1.78 to -0.54) 8.69 (5 to 13) 
EMDR 85 3 -0.99 (-1.76 to -0.23) 10.14 (5 to 15) 
Parent training 49 2 -0.96 (-2.32 to 0.41) 10.28 (3 to 17) 
[TF-CBT] group CBT 171 6 -0.91 (-1.48 to -0.34) 10.72 (6 to 15) 
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Supportive counselling 180 6 -0.59 (-1.29 to 0.12) 12.96 (9 to 16) 
Family therapy 75 1 -0.37 (-1.60 to 0.84) 13.59 (5 to 17) 
EMDR & TAU 10 1 -0.28 (-1.96 to 1.40) 13.65 (4 to 17) 
TAU 158 5 -0.31 (-1.16 to 0.56) 14.51 (10 to 17) 
Waitlist/no treatment 513 16 Reference 15.96 (14 to 17) 
Changes in PTSD symptom scores between baseline and 1-4-month follow-up 
N total = 608; k total = 10;  25 study arms 
Intervention N k Mean SMD (95% CrI) vs waitlist Mean ranking (95% CrI) 
Combined somatic/cognitive therapies 20 1 -1.80 (-3.01 to -0.58) 3.02 (1 to 9) 
[TF-CBT] Cohen TF-CBT/CPT 19 1 -1.74 (-3.09 to -0.42) 3.37 (1 to 10) 
[TF-CBT] group CBT 112 3 -1.51 (-2.48 to -0.61) 4.09 (1 to 9) 
TF-CBT & parent training 12 1 -1.49 (-2.90 to -0.07) 4.33 (1 to 10) 
EMDR & TAU 12 1 -1.10 (-3.51 to 1.23) 6.06 (1 to 12) 
Parent training 20 1 -1.04 (-2.91 to 0.80) 6.30 (1 to 11) 
[TF-CBT] narrative exposure 87 3 -0.94 (-1.84 to -0.04) 6.85 (3 to 11) 
[TF-CBT] exposure/PE 33 2 -0.92 (-2.25 to 0.37) 6.97 (3 to 11) 
Supportive counselling 34 2 -0.74 (-1.41 to 0.06) 7.94 (4 to 11) 
EMDR 43 1 -0.59 (-2.12 to 0.97) 8.48 (2 to 12) 
TAU 25 2 -0.35 (-2.26 to 1.60) 9.52 (3 to 12) 
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Waitlist/no treatment 191 7 Reference 11.08 (8 to 12) 
Remission at treatment endpoint 
N total = 485; k total = 9; 18 study arms 
Intervention N k Mean LOR (95% CrI) vs waitlist Mean ranking (95% CrI) 
[TF-CBT] narrative exposure 13 1 2.81 (0.87 to 5.13) 1.69 (1 to 4) 
[TF-CBT] cognitive therapy 26 2 2.66 (1.28 to 4.22) 1.72 (1 to 3) 
[TF-CBT] exposure/PE 50 2 1.62 (0.22 to 3.04) 2.81 (1 to 4) 
[TF-CBT] Cohen TF-CBT/CPT 158 4 0.89 (0.15 to 1.64) 3.90 (3 to 5) 
Supportive counselling 93 4 0.15 (-0.98 to 1.28) 5.64 (4 to 7) 
Waitlist 103 4 Reference 5.95 (5 to 7) 
TAU 42 1 -0.21 (-1.48 to 1.03) 6.30 (5 to 7) 
CPT: cognitive processing therapy; CrI: credible intervals; EMDR: eye movement desensitisation reprocessing; LOR: log-
odds ratio; SMD: standardised mean difference; PE: prolonged exposure; TAU: treatment as usual; TF-CBT: trauma-
focused cognitive behavioural therapy 
k: number of randomised controlled trials (RCTs) that assessed each intervention in each NMA; N: number randomised to 
each treatment across RCTs in each NMA 
Negative values for the SMD and positive values for the LOR indicate a better effect for the intervention compared with the 
reference treatment (waitlist/no treatment). 
In bold effects where the 95% CrI do not cross the line of no effect (SMD=0 or LOR=0, as relevant) 
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Figure 1. Flow diagram of study selection for the systematic review and the network 
meta-analysis 
 
 
 
 
  
Titles and abstracts identified, N= 
11,568 from systematic search 
Full copies retrieved and 
assessed for eligibility, 
N= 85 
Excluded, N=11,483 
(not relevant population, design, 
intervention, comparison, outcomes, 
unable to retrieve) 
Studies included in 
systematic review, N= 37 
Studies excluded 
from systematic 
review, N= 104 
Additional articles identified from 
2004 guideline, N= 11 
Additional articles identified 
through hand-search (including 
other RQ searches), N= 38 
Studies excluded 
from network meta-
analysis, N= 5 
Studies included in 
network meta-
analysis, N= 32 
Additional articles identified 
through update searches, N= 7 
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Figure 2. Network of interventions for children and young people with PTSD 
The width of lines is proportional to the number of trials in which each direct comparison is 
made. The size of each circle (treatment node) is proportional to the number of people who 
received each treatment. 
 
a. Changes in PTSD symptom scores between baseline and treatment endpoint 
 
b. Changes in PTSD symptom scores between baseline and 1-4-month follow-up 
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c. Remission at treatment endpoint 
 
